CTRI/2023/01/048802已完成未知
Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on Adult Healthy Human Participants.
nilever Industries Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Participants in age group 18 - 65 years (both the ages inclusive).
- •2. Healthy male & female participants with skin types as defined in the population.
- •3. Participants in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data.
- •4. Participants of any skin type providing the skin pigmentation will allow discernment of erythema
- •5. Participants able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.
- •6. Participants willing to give a voluntary written informed consent.
- •7. Participants willing to maintain the patch in position for 24 hours.
- •8. Participants having not participated in a similar investigation in the past two weeks.
- •9. Participants willing to come for regular follow up visits.
- •10. Participants ready to follow instructions during the study period.
排除标准
- •1. Participants with infection, allergy, psoriasis and/or active atopic dermatitis/eczema on the tested area.
- •2. Athletes and participants with history of excessive sweating.
- •3. Participants with cutaneous disease which may influence the study result.
- •4. Participants on oral corticosteroid.
- •5. Participants participating in any other cosmetic or therapeutic trial or have participated in a similar investigation in the past two weeks.
- •6. Participants who are currently pregnant or lactating or planning to become pregnant in the period of study.
- •7. Participants with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
- •8. More than one participant selected/participating from one family/household.
- •9. Participants working with MSCR
研究者
相似试验
已完成
1 期
Safety of the test products to be checked.CTRI/2023/09/057621ITC Life Sciences Technology Centre24
已完成
不适用
Evaluation of the safety of the product by skin sensitivity test on healthy human volunteers.CTRI/2016/12/007573ITC Life Sciences and Technology Centre24
已完成
不适用
Dermatology study in healthy volunteersCTRI/2017/02/007875ITC Life Sciences and Technology Centre24
已完成
不适用
24 Hrs primary irritation patch test on healthy human volunteers.MSCR/ITPT/2013-05CTRI/2013/05/003639ITC R D Centre24
已完成
不适用
To evaluate the safety of products by skin sensitivity test on human male and female subjectsCTRI/2017/05/008561ITC Life Sciences Technology Centre24
